Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2019-06-17
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcricoid Injection vs. Spray as You go Method for Local Anaesthesia During Bronchoscopy
NCT02981277
1% vs. 2 % Lignocaine for Flexible Bronchoscopy
NCT02701179
Two-staged Approach in Positioning Endobronchial Blockers Without Fiberoptic Guidance
NCT02981537
Topical Anesthesia / Bronchoscopy
NCT02237651
Comparison of Endotracheal Intubation Using Flexible Fiberoptic Bronchoscopy Versus Flexible Intubation Video Endoscope (FIVE) in Obese Patients Undergoing Elective Surgeries Under General Anesthesia: A Randomized Controlled Trial
NCT03423563
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group DR
Patients sedated with dexmedetomidine and remifentanil.
Dexmedetomidine
Dexmedetomidine was used as a sedation agent with less side effect on respiratory system.
Remifentanil
Remifentanil was used to prevent cough induced by bronchoscopy.
Group LMA
General anesthesia was applied using laryngeal mask.
Laryngeal mask
Laryngeal mask was used to ensure respiration function during general anesthesia.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexmedetomidine
Dexmedetomidine was used as a sedation agent with less side effect on respiratory system.
Remifentanil
Remifentanil was used to prevent cough induced by bronchoscopy.
Laryngeal mask
Laryngeal mask was used to ensure respiration function during general anesthesia.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult patients aged 18 to 65 years
* American Society of Anesthesiologists (ASA) Physical Status Classification I-II
* BMI 18.5-25kg/m2
* Subjects provide informed consent
Exclusion Criteria
* Coagulation disorder
* Repeat bronchoscopy (more than 3 times)
* Severe liver and renal dysfunction
* Cardiovascular and cerebrovascular diseases
* Pregnancy
* Chronic opioid user
* Drug abusers or addicts
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Zhongshan Hospital
OTHER
Ruijin Hospital
OTHER
Shanghai Pulmonary Hospital, Shanghai, China
OTHER
Changhai Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jia-feng Wang
Clinical Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Anesthesiology, Changhai Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SED-TFB2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.